EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,135,024 | -5.2% | 273,721 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $2,252,724 | +13.5% | 273,721 | 0.0% | 0.01% | +7.7% |
| Q1 2023 | $1,984,477 | -18.3% | 273,721 | 0.0% | 0.01% | -23.5% |
| Q4 2022 | $2,427,905 | -27.5% | 273,721 | 0.0% | 0.02% | -32.0% |
| Q3 2022 | $3,350,000 | +3.5% | 273,721 | 0.0% | 0.02% | +13.6% |
| Q2 2022 | $3,238,000 | -37.8% | 273,721 | 0.0% | 0.02% | -26.7% |
| Q1 2022 | $5,206,000 | -28.4% | 273,721 | 0.0% | 0.03% | -21.1% |
| Q4 2021 | $7,267,000 | -35.4% | 273,721 | 0.0% | 0.04% | -40.6% |
| Q3 2021 | $11,244,000 | -42.2% | 273,721 | -20.4% | 0.06% | -43.9% |
| Q2 2021 | $19,468,000 | +34.9% | 343,721 | 0.0% | 0.11% | +25.3% |
| Q1 2021 | $14,436,000 | -59.0% | 343,721 | -31.6% | 0.09% | -62.1% |
| Q4 2020 | $35,214,000 | +539.8% | 502,274 | +156.1% | 0.24% | +445.5% |
| Q3 2020 | $5,504,000 | +676.3% | 196,142 | +273.1% | 0.04% | +633.3% |
| Q3 2016 | $709,000 | – | 52,573 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |